JPRN-UMIN000003195
Completed
未知
Clinical study on the resistance to antihypertensive therapy in patients with diabetes mellitus - CORE-AT-DM
Komono Kosei Hospital0 sites100 target enrollmentFebruary 17, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Komono Kosei Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Exclusion criteria are: secondary hypertension; history of myocardial infarction, heart failure, angina pectoris, or stroke; uncontrolled diabetes mellitus (HbA1c \>9\.0%); a disorder that required treatment with angiotensin converting enzyme inhibitors, angiotensin receptor blockers, calcium channel blockers, diuretics, or beta\-blockers; renal artery stenosis; serum creatinine of 2\.0mg/dl or more; pregnant women; or clinic systolic blood pressure \>200mmHg and/or diastolic blood pressure \>110mmHg.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Trin Panchmool Kwath in HypertensioHealth Condition 1: I10- Essential (primary) hypertensionCTRI/2019/11/022015Principal Rajiv Gandhi government Ayurvedic college Paprola
Completed
Phase 4
A study of drugs given in hypertension and evaluation of cardiovascular risk in hypertensive post-menopausal womeHealth Condition 1: null- HYPERTENSIOCTRI/2017/06/008779Govt Medical College Patiala300
Completed
Not Applicable
Research for antihypertensive prescription and office blood pressure associated home blood control in Japan, and association of orthostatic blood pressure changes with antihypertensive regimens.HypertensionJPRN-UMIN000009466Japanese Medical and Dental Practitioners for the Improvement of Medical Care20,000
Completed
Phase 4
Examination of effects of aggressive antihypertensive therapy on renal and vascular endothelial functioHypertensionJPRN-UMIN000001629Study group for vascular protection200
Completed
Phase 2
A study to compare the reduction in blood pressure benefits of 2 drugs Azilsartan and Cilnidipine in sugar patients.Health Condition 1: -CTRI/2019/05/019168Dr SHAMEEMUNISHA64